✦ LIBER ✦

Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone

✍ Scribed by Apostolia M. Tsimberidou; Daniel Catovsky; Ellen Schlette; Susan O'Brien; William G. Wierda; Hagop Kantarjian; Guillermo Garcia-Manero; Sijin Wen; Kim-Anh Do; Susan Lerner; Michael J. Keating

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 355 KB
Volume: 107
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21931

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Splenic marginal zone lymphoma with or w

Splenic marginal zone lymphoma with or without villous lymphocytes : Hematologic findings and outcomes in a series of 57 patients

✍ Emilio Iannitto; Achille Ambrosetti; Emanuele Ammatuna; Maura Colosio; Ada M. Fl 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Splenectomy influences bone marrow infil

Splenectomy influences bone marrow infiltration in patients with splenic marginal zone cell lymphoma with or without villous lymphocytes

✍ Vito Franco; Ada Maria Florena; Mario Stella; Aroldo Rizzo; Emilio Iannitto; Ger 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 712 KB

Outcome of patients with nasal natural k

Outcome of patients with nasal natural killer (NK)/T-cell lymphoma treated with radiotherapy, with or without chemotherapy

✍ Ivan Weng Keong Tham; Khai Mun Lee; Swee Peng Yap; Susan Li-Er Loong 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 1 views

Background. This study reviews the outcome of patients with nasal natural killer (NK)/T-cell lymphoma treated at the Therapeutic Radiology Department, National Cancer Centre, Singapore, from 1997 to 2003. Methods. Twenty-one consecutive patients treated with radiotherapy, with or without chemothera

Combination therapy with rituximab and i

Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type

✍ Antonio Salar; Eva Domingo-Domenech; Cristina Estany; Miguel A. Canales; Fernand 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 3 views

Oxaliplatin-based chemotherapy (dexameth

Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin) ± rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma

✍ Luigi Rigacci; Alberto Fabbri; Benedetta Puccini; Ida Chitarrelli; Annalisa Chia 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

High-dose sequential chemotherapy and pe

High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma : A multicenter study of the Intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence

✍ Corrado Tarella; Alessandra Cuttica; Umberto Vitolo; Marina Liberati; Massimo Di 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

## Abstract ## BACKGROUND The objective of the current study was to evaluate in a multicenter setting the feasibility and efficacy of a high‐dose sequential (HDS) chemotherapy regimen that combined intensive debulking and high‐dose therapy (HDT) with peripheral blood progenitor cell (PBPC) autogra